Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 22, 2024

BUY
$191.17 - $325.63 $492,453 - $838,822
2,576 Added 8.47%
32,998 $10.7 Million
Q4 2023

Feb 05, 2024

BUY
$160.99 - $215.69 $4.9 Million - $6.56 Million
30,422 New
30,422 $5.8 Million
Q2 2023

Aug 09, 2023

SELL
$223.05 - $302.68 $44,386 - $60,233
-199 Reduced 4.22%
4,514 $1.29 Million
Q1 2023

May 03, 2023

SELL
$175.41 - $217.92 $2.1 Million - $2.61 Million
-11,983 Reduced 71.77%
4,713 $1.02 Million
Q4 2022

Feb 07, 2023

SELL
$204.38 - $296.82 $146,540 - $212,819
-717 Reduced 4.12%
16,696 $3.43 Million
Q3 2022

Nov 10, 2022

SELL
$195.21 - $310.53 $26,353 - $41,921
-135 Reduced 0.77%
17,413 $4.84 Million
Q2 2022

Jul 29, 2022

BUY
$115.91 - $214.48 $1.21 Million - $2.24 Million
10,432 Added 146.6%
17,548 $3.36 Million
Q1 2022

May 02, 2022

BUY
$127.96 - $207.36 $910,563 - $1.48 Million
7,116 New
7,116 $1.48 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Beck Bode, LLC Portfolio

Follow Beck Bode, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Bode, LLC with notifications on news.